我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

冠心病介入治疗后血糖水平对临床疗效及预后的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2016年第3期
页码:
302-304
栏目:
临床研究
出版日期:
2016-01-05

文章信息/Info

Title:
Effect of blood sugar levels on clinical treatment and prognosis in coronary heart disease patients with diabetes
作者:
祝恒山; 方汉军; 漆 秦; 席 晓
（延安大学咸阳医院心脏外科，陕西 咸阳 712000）
Author(s):
ZHU Heng-shan;  FANG Han-jun;  QI Qin;  XI Xiao
(Department of Cardiac Surgery, Xianyang Hospital, Yanan University, Xianyang 712000, Shaanxi, China)
关键词:
冠状动脉疾病; 糖尿病; 血糖; 预后
Keywords:
coronary disease;  diabetes;  blood glucose;  prognosis
分类号:
R541.4；R581.7
DOI:
-
文献标识码:
A
摘要:
目的 观察冠心病介入治疗后患者血糖水平对临床疗效以及预后的影响。方法 将来咸阳医院就诊的120例冠心病介入治疗患者，按患者血糖水平，将其分为3组：非糖尿病组〔空腹血糖（FPG）<7.0 mmol/L，n=30〕、糖尿病低血糖组（8.0 mmol/L>FPG≥7.0 mmol/L,n=50）和糖尿病高血糖组（FPG≥8.0 mmol/L，n=40）。记录临床资料以及分析生化指标〔血清总胆固醇(TC)、低密度脂蛋白胆固醇（LDL-C）、载脂蛋白水平、三酰甘油（TG）、纤维蛋白原（Fib）以及尿酸（UA）水平〕,并分析急性心肌梗死并发症的发生率。结果 糖尿病高血糖组TC、LDL-C、载脂蛋白、左室舒张末内径水平分别为（4.9±1.4）mmol/L、（3.3±0.9）mmol/L、（1.6±0.5）mmol/L和（55±7）mm，显著高于糖尿病低血糖组的（4.1±0.8）mmol/L、（2.7±0.5）mmol/L、（1.1±0.4）mmol/L、（51±8）mm (均P<0.05)，糖尿病低血糖组相应指标水平显著高于非糖尿病组的（3.7±1.2）mmol/L、（2.2±0.6）mmol/L、（0.7±0.1）mmol/L和（44±7）mm(均P<0.05)。3组TG、Fib以及UA水平无统计学差异。非糖尿病组患者术后发生急性心肌梗死（AMI）、AMI并发恶性心律失常、AMI并发心衰以及病死率分别为：13%、10%、10%和3%；糖尿病低血糖组为：24%、26%、24%和8%。糖尿病高血糖组为30%、32%、30%和12%。与非糖尿病组比较，糖尿病低血糖组和糖尿病高血糖组相应指标水平均显著升高(均P<0.05)，且糖尿病高血糖组指标水平较糖尿病低血糖组高(均P<0.05)。经过非条件Logistic回归分析后，血糖的OR值（95%CI）为4.6(0.8~21.7)，P<0.05，结果显示血糖水平是独立的预测因素。结论 冠心病患者的血糖水平对于患者的临床疗效和预后有一定影响。
Abstract:
AIM To examine the effect of blood sugar levels on clinical treatment and prognosis in coronary heart disease (CHD) patients with diabetes. METHODSOne hundred and twenty CHD patients from January 2013 to January 2015 in our hospital were selected and divided into CHD without diabetes mellitus group (group A, n=30, fasting glucose<7.0 tendency/L), CHD with diabetes and low blood sugar group (group B, n=50, 8.0 mmol/L>fasting glucose≥7.0 mmol/L), and CHD with diabetes and hyperglycemia group (group C, n=40, fasting glucose 8.0 mmol/L). Blood pressures and biochemical indicators, including serum total cholesterol, low density lipoprotein, apolipoprotein, fibrinogen, triglyceride, uric acid, and the incidence of the complications of acute myocardial infarction were measured and analyzed. RESULTSAverage systolic blood pressure in group A and group B was (138.9±20.3) mmHg and (139.2±21.0) mmHg, and diastolic blood pressure was (82.6±10.5) mmHg and (83.1±11.3) mmHg, with no significant difference (P>0.05). Serum total cholesterol, low density lipoprotein, apolipoprotein levels and left ventricular end-diastolic diameter in group C were significantly higher than those in group B, and these parameters in group B were significantly than those in group A (P<0.05). No statistical difference was observed in triglycerides, fibrinogen and uric acid levels among the three groups. Postoperative acute myocardial infarction, acute myocardial infarction with malignant arrhythmia, incidence of acute myocardial infarction with heart failure and death rate in group A were lower than those in group B and group C (P<0.05), and these rates in group C were higher than those in group B (P<0.05). CONCLUSIONBlood glucose levels in diabetic patients have some influence on biochemical indicators and complications. Good control of blood sugar level has a positive effect on the treatment and prognosis in CHD patients with diabetes mellitus.

参考文献/References

[1]王全河.辛伐他汀联合丹参注射液治疗冠心病合并糖尿病的疗效观察[J].中国医药指南,2012,10(22):134-135.
[2]赵 璐,王艳军,梁 丽,等.冠心病合并糖尿病的冠脉病变严重程度的相关危险因素分析[J].医学信息,2014,(20):566-567.
[3]Wu W,Sun Z,Li Q,et al.Influence of the glucose-lowering rate on left ventricular function in patients with type 2 diabetes and coronary heart disease[J].J Diabetes Complications,2012,26(2):83-88.
[4]Saely CH,Drexel H.Is type 2 diabetes really a coronary heart disease risk equivalent?[J].Vascul Pharmacol,2013,59(1-2):11-18.
[5]张爱民.冠心病、糖尿病及冠心病合并糖尿病患者血脂、血糖水平的比较研究[J].新疆医学,2011,41(9):121-122.
[6]郜 琳,张鹏宇,杨志宏,等.高龄冠心病合并2型糖尿病患者餐后血糖水平与心脏不良事件的相关性研究[J].中国实验诊断学, 2014,18(1):112-113.
[7]王国凤,胡新贵,申晓彧,等.冠心病及冠心病合并糖尿病患者血糖与血浆P-选择素相关性研究[J].中西医结合心脑血管病杂志,2009,7(4):475-477.
[8]Onat A,Can G,?i?ek G,et al.Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes,and coronary disease in non-diabetic adults[J].Acta Diabetol,2013,50(4):519-528.
[9]何 琴,张莉芸,王 勇,等.糖耐量异常或糖尿病合并冠心病患者的冠脉病变分析[J].中国老年学杂志,2013,33(7):1526-1528.

备注/Memo

备注/Memo:
收稿日期：2015-06-18.
作者简介：祝恒山，副主任医师，博士 Email：zhuhengshan@sina.cn
更新日期/Last Update: 2016-01-07